NUCLEAR MEDICINE ROTATION

Subspecialty Chief: Dean Fullingim, DO

Rotation specific core competency goals and objectives

Requirements per ACGME/NRC/AOCR for documenting adequate hours of training.

  •  
    Radiologic physics, instrumentation and radiobiology? [PR IV.A.3.b).(1).(c).(i); IV.A.3.b).(2).(a)]
     
    Patient and medical personnel safety (i.e. radiation protection, MRI safety)? [PR IV.A.3.b).(1).(c).(ii).; IV.A.3.b).(2).(b)]
     
    Chemistry of by-product material for medical use? [PR IV.A.3.b).(1).(c).(iii)]
     
    Biologic and pharmacological actions of materials administered in diagnostic and therapeutic procedures? [PR IV.A.3.b).(1).(c).(iv)]
     
    Topics in safe handling, administration, and quality control of radionuclide doses in clinical medicine? [PR IV.A.3.b).(1).(c).(v)]
     
    Ordering, receiving, and unpacking radioactive material safely and performing the related radiation surveys? [PR IV.A.3.b).(1).(d)]
     
    The safe elution and quality control of radionuclide generator systems? [PR IV.A.3.b).(1).(d)]
     
    Calculating, measuring and safely preparing patient doses? [PR IV.A.3.b).(1).(d)]
     
    Calibration and quality control of survey meters and dose calibrators? [PR IV.A.3.b).(1).(d)]
     
    Safe handling and administration of therapeutic doses of unsealed radionuclide sources? [PR IV.A.3.b).(1).(d)]
     
    Written directives? [PR IV.A.3.b).(1).(d)]
     
    Response to radiation spills and accidents? [PR IV.A.3.b).(1).(d)]
     
    Radiation signage and related materials? [PR IV.A.3.b).(1).(d)]
     
    Using administrative controls to prevent medical events involving the use of unsealed byproduct material? [PR IV.A.3.b).(1).(d)]
     
    Appropriate imaging utilization? [PR IV.A.3.b).(2).(c)]
     
    Fundamentals of molecular imaging? [PR IV.A.3.b).(2).(e)]
     
    Biological and pharmacologic actions of materials administered in diagnostic or therapeutic procedures? [PR IV.A.3.b).(2).(f)]
     
    Will each resident participate in at least 3 low dose therapies involving oral administration of I-131 and at least 3 high dose therapies involving oral administration of I-131? [PR IV.A.5.a).(2).(a)]
    • Will this include participation in patient selection, informed consent, understanding and calculating the administered dose, counseling of patients and their families on radiation safety issues and patient follow up? [PR IV.A.5.a).(2).(a).(i)]
    Close

Resources: Media and Books

Stacks Image 72238

Forms to be printed and filled out. Upload completed form to myPortfolio.